Casay Biotech has four core technologies. It has four core technologies, including the use of synthetic biology methods to develop microbial metabolic pathways and the construction of high-efficiency engineering bacterial microbial metabolism regulation and microbial high-efficiency transformation technology bioconversion/fermentation systems. Separation and purification technology, polymerization process and its downstream application development technology
In the market competition in recent years, traditional chemical long-chain dibasic acids (mainly DC12 lauric acid, etc.) represented by Invista have gradually Exiting the market
At the same time, with the support of core technology, the domestic and international market shares of Cathay Bio's carbon chain dibasic acid are as high as 95% and 80% respectively. At present, there is no public information at home and abroad except Cathay Bio that there are other achievable As a company that industrializes long-chain dibasic acids, Cathay Biotech has a more prominent position in the competition in the bio-method long-chain dibasic acid industry
Among the four core technologies owned by Cathay Biotech, it is worth mentioning Proposed separation and purification technology that breaks through the industrialization of bioconversion/fermentation systems
This core technology is a key step in obtaining high-quality products from complex biological fermentation systems and also determines the large-scale industrialization of biomanufacturing. Important technical bottlenecks in practice. The company's long-chain dibasic acid separation and purification technology can efficiently and cost-effectively control key impurities in products at very low levels (ppm level). The company has a one-step membrane filtration extraction process to recover long-chain dibasic acids. The rate reaches over 98, and there are further product refining technologies such as solvent crystallization, as well as molecular distillation, chromatographic separation, and multiple extraction and purification methods such as one-step crystallization from the fermentation broth. These methods can be substituted for each other or used in combination
The company's project The core technology is a systematic separation and purification platform to achieve an efficient impurity removal process in bio-manufacturing, which improves the extraction and purification efficiency of the company's products. Through this core technology, the company realizes the bio-based long-chain dibasic acid series products and bio-based pentanediamine products in Efficient separation and purification in the biological manufacturing process
In addition to mastering the four major technologies, Cathay Biotech has hundreds of patents. As of March 31, 2020, the company has obtained 120 overseas authorized patents